Madrigal Pharmaceuticals Inc (MDGL)
290.00
-12.67
(-4.19%)
USD |
NASDAQ |
Nov 15, 09:50
Madrigal Pharmaceuticals Free Cash Flow (Quarterly): -67.76M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -67.76M |
| June 30, 2024 | -140.08M |
| March 31, 2024 | -149.51M |
| December 31, 2023 | -80.97M |
| September 30, 2023 | -85.26M |
| June 30, 2023 | -75.38M |
| March 31, 2023 | -84.10M |
| December 31, 2022 | -58.54M |
| September 30, 2022 | -59.10M |
| June 30, 2022 | -57.46M |
| March 31, 2022 | -49.96M |
| December 31, 2021 | -48.16M |
| September 30, 2021 | -45.61M |
| June 30, 2021 | -46.88M |
| March 31, 2021 | -43.47M |
| December 31, 2020 | -54.96M |
| September 30, 2020 | -47.85M |
| June 30, 2020 | -24.26M |
| March 31, 2020 | -30.82M |
| December 31, 2019 | -12.42M |
| September 30, 2019 | -11.32M |
| June 30, 2019 | -11.54M |
| March 31, 2019 | -6.519M |
| December 31, 2018 | -6.273M |
| September 30, 2018 | -5.251M |
| Date | Value |
|---|---|
| June 30, 2018 | -5.36M |
| March 31, 2018 | -8.645M |
| December 31, 2017 | -5.945M |
| September 30, 2017 | -4.951M |
| June 30, 2017 | -7.773M |
| March 31, 2017 | -3.773M |
| December 31, 2016 | -5.282M |
| September 30, 2016 | -9.244M |
| June 30, 2016 | -2.647M |
| March 31, 2016 | -0.438M |
| December 31, 2015 | -1.096M |
| September 30, 2015 | 34.49M |
| June 30, 2015 | -17.76M |
| March 31, 2015 | -18.78M |
| December 31, 2014 | -19.27M |
| September 30, 2014 | -18.60M |
| June 30, 2014 | -20.90M |
| March 31, 2014 | -20.29M |
| December 31, 2013 | -18.77M |
| September 30, 2013 | -16.60M |
| June 30, 2013 | -20.31M |
| March 31, 2013 | -22.49M |
| December 31, 2012 | -12.61M |
| September 30, 2012 | -13.47M |
| June 30, 2012 | -13.16M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-149.51M
Minimum
Mar 2024
-12.42M
Maximum
Dec 2019
-63.13M
Average
-56.21M
Median
Free Cash Flow (Quarterly) Benchmarks
| ADMA Biologics Inc | 23.93M |
| 89bio Inc | -145.36M |
| Corcept Therapeutics Inc | 72.19M |
| Sarepta Therapeutics Inc | -107.96M |
| Matinas BioPharma Holdings Inc | -3.106M |